47 results on '"Nyolczas, Noémi"'
Search Results
2. The Impact of Specialised Heart Failure Outpatient Care on the Long-Term Application of Guideline-Directed Medical Therapy and on Prognosis in Heart Failure with Reduced Ejection Fraction
3. Cardiopoietic cell therapy for advanced ischemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial
4. A csökkent ejekciós frakciójú szívelégtelenség gyógyszeres kezelésének változása és a prognózisra gyakorolt hatása a hazai gyakorlatban.
5. Incidence and predictors of heart failure with improved ejection fraction category in a HFrEF patient population.
6. Incidence and predictors of heart failure with improved ejection fraction category in a HFrEF patient population
7. Combination of Hydralazine and Isosorbide-Dinitrate in the Treatment of Patients with Heart Failure with Reduced Ejection Fraction
8. The effect of kidney function on guideline‐directed medical therapy implementation and prognosis in heart failure with reduced ejection fraction.
9. A vesefunkció hatása a gyógyszeres terápia optimalizálására és a mortalitásra csökkent ejekciós frakciójú szívelégtelenségben
10. Long-Term Efficacy and Safety of Left Atrial Appendage Closure Procedures
11. Unrecognised cardiovascular disease in type 2 diabetes: is it time to act earlier?
12. The optimization of guideline-directed medical therapy during hospitalization among patients with heart failure with reduced ejection fraction in daily clinical practice
13. Cell therapy for human ischemic heart diseases: Critical review and summary of the clinical experiences
14. Combination of Hydralazine and Isosorbide-Dinitrate in the Treatment of Patients with Heart Failure with Reduced Ejection Fraction
15. A háromér-betegség kezelése a FAME-3 vizsgálat eredményeinek tükrében
16. The Genetic Architecture of Hypertrophic Cardiomyopathy in Hungary: Analysis of 242 Patients with a Panel of 98 Genes
17. The Optimization of Guideline-Directed Medical Therapy during Hospitalization among Patients with Heart Failure with Reduced Ejection Fraction in Daily Clinical Practice.
18. Time Course of Endothelium-Dependent and -Independent Coronary Vasomotor Response to Coronary Balloons and Stents: Comparison of Plain and Drug-Eluting Balloons and Stents
19. Variant Transthyretin Amyloidosis (ATTRv) in Hungary: First Data on Epidemiology and Clinical Features
20. 2-Year Results of the AUTAX (Austrian Multivessel TAXUS-Stent) Registry: Beyond the SYNTAX (Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery) Study
21. Proportion of Patients Eligible for Cardiac Contractility Modulation: Real-Life Data from a Single-Center Heart Failure Clinic
22. Design and rationale for the Myocardial Stem Cell Administration After Acute Myocardial Infarction (MYSTAR) Study: A multicenter, prospective, randomized, single-blind trial comparing early and late intracoronary or combined (percutaneous intramyocardial and intracoronary) administration of nonselected autologous bone marrow cells to patients after acute myocardial infarction
23. The impact of serum concentration‐guided digoxin therapy on mortality of heart failure patients: A long‐term follow‐up, propensity‐matched cohort study
24. Prediction of the Effect of Bisoprolol in Dilated Cardiomyopathy
25. Közepes (HFmrEF) és megtartott ejekciós frakciójú szívelégtelenség (HFpEF)
26. Combined delivery approach of bone marrow mononuclear stem cells early and late after myocardial infarction: the MYSTAR prospective, randomized study
27. HFmrEF: Közepes ejekciós frakciójú szívelégtelenség
28. Cardiac Index by Transthoracic Echocardiography (CITE) study
29. A levoszimendán perioperatív alkalmazása a szívsebészetben. Magyar ajánlás
30. Hyperkalaemia szívelégtelenségben. Új kezelési lehetőségek a láthatáron
31. A 2016-ban publikált új ESC szívelégtelenség irányelv krónikus szívelégtelenség diagnózisára és kezelésére vonatkozó ajánlásai
32. Magyar Szívelégtelenség Regiszter 2015–2016. Kezdeti eredmények
33. Újdonságok a krónikus szívelégtelenség gyógyszeres terápiájában
34. Natriureticus peptidek mérése szívelégtelen betegekben: a helyes laboratóriumi és klinikai gyakorlat
35. Combined delivery approach of bone marrow mononuclear stem cells early and late after myocardial infarction: the MYSTAR prospective, randomized study
36. 1373 Effectiveness of patient education in a Hungarian heart failure outpatient clinic
37. Central effects of the potent and highly selective μ opioid antagonist (CTOP) in mice
38. Effectiveness of patient education in a Hungarian heart failure outpatient clinic
39. Analgesic and tolerance-inducing effects of the highly selective δ opioid agonist enkephalin in mice
40. [Rapid up-titration of guide-directed medical therapy after a heart failure hospitalisation].
41. [The changes in the pharmacotherapy of heart failure with reduced ejection fraction and its effect on prognosis: experience in the Hungarian clinical practice].
42. [The effect of kidney function on the optimization of medical therapy and on mortality in heart failure with reduced ejection fraction].
43. Treatment of three-vessel disease in light of the results of the FAME-3 study
44. [Perioperative use of levosimendan in cardiac surgery. Hungarian recommendation].
45. [Hungarian Heart Failure Registry 2015-2016. Preliminary results].
46. [Novelties in the pharmacological treatment of chronic heart failure].
47. [Measurement of natriuretic peptides in heart failure: the good laboratory and clinical practice].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.